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Abstract
An acidic phospholipase A2 (EC-I-PLA2) has been purified from the Indian saw-scaled
viper (Echis carinatus ) venom through a combination of column chromatography and
electrophoresis. EC-I-PLA2 has a molecular weight of 16000 by SDS-PAGE. It was
focussed between pH 4.2 and 4.8 by isoelectro focussing. EC-I-PLA2 was non-lethal to mice
and devoid of neurotoxicity, myotoxicity, anticoagulant activity and cytotoxicity. It induced
mild oedema in the foot pads of mice. The purified PLA2 inhibited ADP, collagen and
epinephrine induced human platelet aggregation and the inhibition was both dose and time
dependent. # 1999 Elsevier Science Ltd. All rights reserved.
1. Introduction
Phospholipase A2 (EC.3.1.1.4., PLA2) is an esterolytic enzyme which catalyzes
the hydrolysis of the 2-acyl groups in sn-3 phosphoglycerides. The hydrolytic
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products are fatty acids and lysophosphoglycerides (Dennis, 1983). The
multimolecular forms of PLA2 are widely distributed in nature. The richest
sources of PLA2 are the exocrine secretions of mammalian pancreas and the
venom of snakes and bees. It is not surprising therefore that the best characterized
PLA2 have been isolated from these sources. PLA2 enzymes from pancreas and
snake venoms undoubtedly serve a digestive function. However, in addition, the
latter have evolved into lethal toxins with target specific actions. Hence, these
induce a spectrum of pharmacological eects such as pre or postsynaptic
neurotoxicity, myotoxicity, cardiotoxicity, initiation or inhibition of platelet
aggregation, haemolytic, convulsant, hypotensive, anticoagulant and oedema
inducing activities (Kini and Evans, 1989, and references therein).
The saw-scaled vipers (genus Echis ) have an extensive geographical distribution
(for references see Gillissen et al., 1994). Their venom is a complex mixture of
predominantly high molecular weight proteins, peptide toxins and glycoproteins
(Desmond et al., 1991). There are reports on the variation in the composition of
their venom due to geographical distribution. (Iddon et al., 1988; Gillissen et al.,
1994). Their bites primarily cause severe bleeding and haemorrhage. Several
biologically active components have been isolated and studied from their venoms
(for references see Gillissen et al., 1994). However, information regarding the
PLA2 enzymes of Echis venoms is limited. In the present study we report the
purification and characterization of a platelet aggregation inhibitor PLA2 from
Indian saw-scaled viper (Echis carinatus ) venom.
2. Materials and methods
Lyophilized Echis carinatus venom was purchased from Irula Snake Catcher’s,
Madras, India. CM-Sephadex C-25 (4.5 meq/g) and low molecular weight markers
were from Pharmacia Fine Chemicals, Uppsala, Sweden. Bio-Gel P-30 was from
Bio-Rad Labs., Richmond, USA. Linoleic acid, a-nitroso-b-naphthol, broad range
ampholytes (pH, 3–10) gel filtration molecular weight marker proteins, ADP,
collagen and epinephrine were purchased from Sigma, St. Louis, USA.
Phosphatidyl choline (PC) from hen’s egg yolk was prepared according to the
method of Singleton et al. (1965). Male Swiss Wistar mice (20–22 g) were from
Central Animal House, University of Mysore, India. All other chemicals and
reagents were of analytical grade and the solvents were redistilled before use.
2.1. CM-Sephadex C-25 column chromatography
Echis carinatus venom was fractionated on a CM-Sephadex C-25 column as
described previously (Kemparaju et al., 1994). Briefly, whole venom (660 mg) in 4
ml 0.02 M phosphate buer pH 7.0 was applied to a column (1.2  110 cm)
previously equilibrated with the same buer. The column was eluted stepwise
using phosphate buer of various molarities (0.02–0.3 M) and pH 7.0–8.0.
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Fractionation was carried out at 208C at a flow rate of 40 ml/h and 5 ml fractions
were collected. The protein elution was monitored at 280 nm. The non-retained
acidic fraction is now designated as EC-IC-PLA2.
2.2. Electrophoresis
EC-IC-PLA2 was subjected to electrophoresis on 7.5% polyacrylamide gels (0.3
 13 15 cm) as described by Davis (1964). A total of 330 mg (each time 30 mg
in 1.5 ml saline) was subjected to PAGE using Tris–glycine buer pH 8.3 with a
current of 50 mA at 208C for 6 h. After electrophoresis, a portion of the gel
(about 2 cm) was sliced longitudinally and stained for proteins with 0.1%
Coomassie brilliant blue R-250. The non-stained gel portion was sliced
corresponding to the protein bands of the stained gel piece. Proteins from the gel
slices were separately electroeluted providing similar conditions for 12 h. Proteins
were collected in 3000 cut o dialysis bags. The most acidic protein fraction which
moved along with the dye band was called EC-IE-PLA2.
2.3. Bio-Gel P-30 column chromatography
EC-IE-PLA2 (12 mg) in 4 ml 0.1 M NaCl containing 2% sodium dodecyl
sulfate (SDS) was thoroughly mixed and kept at 378C for 1 h. It was then loaded
onto Bio-Gel P-30 column (1.5  70 cm) which was pre-equilibrated with 0.1 M
NaCl. The column was eluted using 0.1 M NaCl with a flow rate of 20 ml/h and 3
ml fractions were collected at 208C. Protein elution was monitored at 280 nm
using a spectrophotometer. Individual protein peaks were pooled and dialyzed in
saline before use.
2.4. Phospholipase A2 activity
The assay mixture (1 ml) contained 1 mmol egg PC, 0.3 ml diethyl ether, 50 mM
Tris–HCl buer pH 7.5, 40 mmol Ca2+ and 25 mg enzyme. The free fatty acid
released by the action of enzyme on PC was estimated as described by Bhat and
Gowda (1989). The specific activity was expressed as nmol free fatty acid released/
min/mg protein. For Km determination, 0–2.2 mmol PC was used in the assay
mixture.
The positional specificity was determined using autoclaved E. coli cells with the
phospholipids labeled at sn-2 position with (14C) oleate as described by Franson et
al. (1974).
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2.5. Molecular weight determination
The molecular weight of purified PLA2 was determined by gel filtration on a
Sephadex G-50 column (90  1 cm) according to the method of Andrews (1964).
Insulin (6000), lysozyme (14,000), soyabean trypsin inhibitor (20,100) and carbonic
anhydrase (29,000) were used as standard markers. Sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE; 15%) was carried out according
to the method of Laemmli (1970). Low molecular weight marker proteins (14–90
kDa) were used. The gel was stained with 0.1% Coomassie brilliant blue R-250.
2.6. Isoelectric focussing
Isoelectric focussing was carried out using Pharmacia 2117 multiphor II
electrophoresis system on 7.5% polyacrylamide gel using ampholine with a pH
range of 3–10 (Vesterberg, 1972). A portion of the gel was stained for the protein
and the remaining portion was cut into 0.5 cm transverse slabs and soaked in 4 ml
distilled water for pH determination.
2.7. Fluorescence and protein determination
Fluorescence emission of 28 nmol protein in 2 ml saline was recorded after
exciting at 280 nm in a Shimadzu RF 5000 spectrofluorimeter. Protein
concentration was determined as described by Lowry et al. (1951).
2.8. Preparation of platelet rich and platelet poor plasma
The method of Ardlie and Han (1974) was employed. Human blood was
collected from the vein of healthy donors who were non-smokers and had not
taken any medication for the previous 15 days. Nine volumes of the blood were
collected into 1 volume of acid citrate dextrose (93 mM sodium citrate, 7 mM
citric acid and 140 mM glucose pH 6.5). The citrated blood was immediately
centrifuged for 10 min at 90 g at room temperature. The supernatant was called
platelet rich plasma (PRP). The remaining blood was centrifuged for 15 min at
500  g and the supernatant obtained was the platelet poor plasma (PPP). The
platelet concentration of PRP was adjusted with PPP to 225,000225,000 platelets/
ml. The PRP was kept at 378C and was used within 2 h. All the above
preparations were carried out using plasticwares or siliconized glasswares.
2.9. Platelet aggregation
The turbidimetric method of Born (1962) was followed using a chronolog dual
channel aggregometer connected to a omniscribe dual pen recorder to record the
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light transmission as a function of time. Aliquots of PRP (0.45 ml) were
preincubated with PLA2 toxin (0–20 mg/0.45 ml PRP) for 2 min in a siliconized
cylindrical glass cuvette under constant stirring. The aggregation was initiated by
the addition of agonists such as ADP (76 mM), collagen (approximately 2 mg/ml)
and epinephrine (22 mM) separately. The aggregation was followed for a period of
4 min. The aggregation trace is the plot of light transmission between PRP and
PPP baseline, which represent 0% and 100% aggregation, respectively. Percent
inhibition of aggregation was calculated using the value of control (without PLA2
toxin) to be 100%.
2.10. Oedema inducing activity
The procedure of Yamakawa et al. (1976), modified by Vishwanath et al. (1987)
was followed. Groups of six mice were injected in the right foot pads with
dierent doses of PLA2 in 20 ml saline. The left foot pads received 20 ml saline
which served as controls. The increase in weight due to oedema was calculated as
the oedema ratio by the following equation:
Oedema ratio  weight of the oedematous leg 100
weight of normal leg
:
Minimum oedema dose is the amount of protein required to cause an oedema
ratio of 120%.
2.11. Determination of LD50, myotoxicity, cytotoxicity and anticoagulant activity
The method of Meier and Theakston (1986) was followed for LD50
determination. Myotoxicity was determined by the method of Gutierrez et al.
(1989). EC-I-PLA2 as i.p. dose of 14 mg/kg body weight was injected into a group
of six mice. After 2 h blood samples were drawn by retroorbital puncture and
lactate dehydrogenase activity was determined in the serum samples using Span
diagnostic kit. Cytotoxicity was determined based on trypan blue exclusion using
Ehrlich ascites tumor cells grown in the peritoneal cavity of Swiss albino mice
according to the method of Chwetzo et al. (1989). Anticoagulant activity was
measured by prothrombin times according to the method of Quick (1966).
2.12. Haemolytic activity
Direct and indirect haemolytic activity was assayed by the method of Boman
and Kaletta (1957). Freshly collected human red blood cells from healthy donors
were used for the assays. Activity was expressed as percentage of haemolysis.
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3. Results and discussion
An acidic PLA2, EC-I-PLA2, has been purified from Indian saw-scaled viper
venom. The purification was achieved using CM-Sephadex C-25 column
chromatography, PAGE followed by gel filtration on a Bio-Gel P-30 column (Fig.
1). PAGE pattern of EC-IC-PLA2 recovered from CM-Sephadex C-25 column is
shown in Fig. 2A. After electroelution, about 90% of the protein and 125% of the
phospholipase activity were recovered from the gel slices (data not shown). The
fast moving protein band, EC-IE-PLA2, contributed for about 4% of the protein
and 31% of the phospholipase activity loaded onto PAGE. EC-IE-PLA2,
although it gives a single band in PAGE (Fig. 2B), showed 2 bands in SDS-PAGE
(Fig. 3B). EC-IE-PLA2, when subjected to gel filtration on a Bio-Gel P-30
column, and in the presence of 8 M urea or 7 M guanidinium hydrochloride
eluted as a single peak (not shown). However, in the presence of 2% SDS upon
gel filtration, EC-IE-PLA2 was resolved into three peaks (Fig.1). This suggested
that EC-IE-PLA2 is an association of three proteins with dierent molecular
weight. The first and last peak did not show phospholipase activity, but
contributed for about 4% and <1% of the protein loaded on to the column,
respectively. The middle major peak designated as EC-I-PLA2 showed
phospholipase activity. About 89% of the protein and 132% of the activity loaded
on to the column were recovered in this peak. A summary of the purification of
EC-I-PLA2 is given in Table 1. The proteins corresponding to the first and second
peak resolved in gel filtration are also seen in the SDS-PAGE pattern of EC-IE-
Fig. 1. Bio-Gel P-30 column chromatography of EC-IE-PLA2. (—) corresponds to EC-I-PLA2.
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PLA2, but the protein of the third peak was not noticed in the SDS-PAGE
pattern of EC-IE-PLA2. This could possibly be due to its occurrence in trace
amount (<1%).
EC-I-PLA2 was homogeneous as it showed a single band in PAGE (Fig.2C),
SDS-PAGE (Fig. 3C) and isoelectro focussing (not shown). The estimated
molecular weight was 16,000 determined by SDS-PAGE and 15,800 by gel
filtration on a Sephadex G-50 column. The molecular weight agrees with the range
generally reported for monomeric snake venom PLA2 (Desmond et al., 1991;
Kemparaju et al., 1994). The isoelectric point (pI ) was estimated to be between
4.2 and 4.8. This agrees with the pI values reported for two acidic PLA2 (pI 4.6)
of Kenyan E. carinatus leakeyi venom (Desmond et al., 1991). EC-I-PLA2
exhibited a fluorescence emission maximum at 348 nm when excited at 280 nm,
suggesting the exposed tryptophan residues in the molecule.
EC-I-PLA2 released radiolabeled fatty acid from E. coli cells containing
phospholipids specifically labeled at the sn-2 position with (14C) oleate. EC-I-
PLA2 showing a specific activity of 544 nmol/min/mg. Km determination by
double reciprocal plot (Lineweaver and Burk, 1934) was found to be 1.66 mM.
The specific activity and Km values of EC-I-PLA2 are greater than the values
reported for EC-IV-PLA2 (400 nmol/min/mg and 0.25 mM respectively) which is a
basic PLA2 isolated from the same venom (Kemparaju et al., 1994). This
Fig. 2. Polyacrylamide gel electrophoresis. Samples containing 250 mg EC-IC-PLA2 (A), 50 mg EC-IE-
PLA2 (B), and 35 mg EC-I-PLA2(C).
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suggested that EC-I-PLA2 appears to have less anity towards the substrate PC
when compared with EC-IV-PLA2. The pH and temperature optima (pH 7.5 and
378C, respectively) are comparable with the values reported for most of the venom
PLA2.
EC-I-PLA2 exhibited indirect haemolytic activity as it converts lecithin into
lysolecithin which in turn lyses the erythrocyte membrane. About 38% haemolysis
was observed when 25 mg enzyme was incubated for 10 min in the reaction
mixture. EC-I-PLA2 did not show direct haemolytic activity, possibly due to the
inability of the enzyme to hydrolyze inner membrane phospholipids of
erythrocytes (Rosenberg, 1986). EC-I-PLA2 was not lethal to experimental mice
up to an i.p. dose of 14 mg/kg body weight. In contrast, the basic PLA2 isolated
from the same venom (Kemparaju et al., 1994) was toxic with an i.p. LD50 value
of 5 mg/kg body weight. Although this result supports the view that acidic PLA2
is less toxic and enzymatically more active than basic PLA2 (Rosenberg, 1986),
lethal potencies of venom PLA2 can neither be correlated to its catalytic property
nor to its isoelectric point (Dhillon et al., 1987). For instance, an acidic PLA2
from N. naja sputatrix venom (Tan and Arunmozhiarasi, 1989) possess an i.v.
LD50 value of 0.86 mg/kg/body weight in mice, and enzyme activity of 2130 mmol/
min/mg. EC-I-PLA2 induced non-haemorrhagic oedema in the foot pads of mice
Fig. 3. SDS-polyacrylamide gel electrophoresis. Samples containing (A) 200 mg EC-IC-PLA2, (B) 30 mg
EC-IE-PLA2, (C) 15 mg EC-I-PLA2 and (D) molecular weight markers in kDa (from top to bottom)
phosphorylase b (a: 94), bovine serum albumin (b: 67), ovalbumin (C: 43), carbonic anhydrase (d: 30),
soyabean trypsin inhibitor (e: 20.1) and a-lactalbumin (f: 14.4).
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The minimum oedema dose (2.25 mg) agrees with the values reported for the
acidic PLA2 TFV PL-Ia (2.2 mg) and TFV PL-Ib (3 mg) of T. flavoviridis venom
(Vishwanath et al., 1987) and NN-I2c-PLA2 (2.5 mg) and NN-I2e-PLA2 (2.7 mg)
of N. naja naja venom (Rudrammaji and Gowda, 1998).
EC-I-PLA2 inhibited human platelet aggregation when induced separately by
ADP, collagen and epinephrine. The inhibition was both concentration (Fig. 4)
and time (Fig. 5) dependent in all the cases studied. The inhibition was
pronounced with epinephrine and collagen when compared with ADP. At a
concentration of 20 mg EC-I-PLA2, the percent inhibition was 8225, 7227 and 33
2 2 (values are mean2 S.D.; n=3), respectively, for epinephrine, collagen and
ADP induced aggregation. The calculated IC50 values ware 12.8 and 13.8 mg for
collagen and epinephrine induced aggregation, respectively. For ADP induced
aggregation the IC50 value could not be calculated as there was only 33%
inhibition observed when 20 mg EC-I-PLA2 was used in the reaction mixture. The
platelet aggregation inhibition was not tested beyond 20 mg EC-I-PLA2 in all the
cases. Fig. 6 shows the typical aggregation pattern when stimulated by collagen.
Our results agree well with the aggregation properties of two acidic PLA2 isolated
from T. gramineus (Ouyang and Huang, 1983) and A. halys (Ouyang et al., 1983)
venoms, which inhibited thrombin, ADP, collagen, and sodium arachidonate
induced rabbit platelet aggregation. Three acidic PLA2 of N. naja naja venom also
inhibited ADP, collagen and epinephrine induced human platelet aggregation
(Rudrammaji, personal communication). However, EC-I-PLA2 diers from the
aggregation properties of an acidic PLA2 of A. acutus venom (Chen and Chen,
Fig. 4. Eect of EC-I-PLA2 on platelet aggregation induced by ADP (q), collagen (w) and epinephrine
(.). EC-I-PLA2 (0–20 mg/0.45 ml PRP) was preincubated for 2 min at 378C. Platelet aggregation was
initiated separately by the addition of ADP (76 mM), collagen (approximately 2 mg/ml) and epinephrine
(22 mM) and was recorded using platelet aggregometer. Values represent mean 2 S.E.M. of three
experiments.
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Fig. 5. Eect of preincubation time on platelet aggregation induced by ADP (q), collagen (w) and
epinephrine (.). EC-I-PLA2 (5 mg/0.45 ml PRP) was preincubated for dierent time intervals (2–20
min) at 378C. Platelet aggregation was initiated separately by adding ADP (76 mM), collagen
(approximately 2 mg/ml) and epinephrine (22 mM). Aggregation was recorded using platelet
aggregometer. Values represent mean2S.E.M. of three experiments.
Fig. 6. Platelet aggregation trace for inhibition of collagen induced aggregation by EC-I-PLA2. EC-I-
PLA2 (0–20 mg/0.45 ml PRP) was initiated by adding collagen (approximately 2 mg/ml) and recorded
using platelet aggregometer. Each trace is a representative of three experiments.
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1989) which showed biphasic eects on human platelet aggregation. Several PLA2
interfering in platelet function have been isolated and studied from snake venoms
(Kini and Evans, 1990, and references therein). PLA2 which aect platelet
aggregation includes two classes (Kini and Evans, 1989). Class A enzymes exhibit
biphasic eects, where, under certain conditions, they both inhibit and initiate
aggregation, whereas class B PLA2 only inhibit platelet aggregation. Thus EC-I-
PLA2 belongs to the latter class. EC-I-PLA2 is devoid of myotoxicity,
anticoagulant activity and cytotoxicity (on EAT cells).
Thus, in conclusion, EC-I-PLA2, being a non-lethal PLA2, appears to play a
role in the digestion of the prey. However, synergism with other components of
the venom cannot be ruled out in inducing toxic eects.
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